Biogen Pharmachem Industries Limited (BOM:531752)
India flag India · Delayed Price · Currency is INR
0.6400
0.00 (0.00%)
At close: Mar 5, 2026

BOM:531752 Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Net Income
-2.9319.314.56-0.09-16.03
Other Operating Activities
----0-
Change in Accounts Receivable
---25.454.85
Change in Accounts Payable
--18.4-0.610.61
Change in Other Net Operating Assets
-7.890.14-5.91-10.730.07
Operating Cash Flow
-10.8219.4517.0413.9839.5
Operating Cash Flow Growth
-14.09%21.89%-64.60%-
Investment in Securities
-184.0134.1-1925.39-30.44
Investing Cash Flow
-326.19-20.56-16.59-13.23-36.4
Short-Term Debt Repaid
-----3.06
Total Debt Repaid
-----3.06
Net Debt Issued (Repaid)
-----3.06
Issuance of Common Stock
357----
Financing Cash Flow
357----3.06
Miscellaneous Cash Flow Adjustments
--0---
Net Cash Flow
19.99-1.120.460.760.04
Levered Free Cash Flow
-9.582.2511.2716.5854.95
Unlevered Free Cash Flow
-9.582.2511.2716.5854.95
Change in Working Capital
-7.890.1412.4914.0755.53
Source: S&P Global Market Intelligence. Standard template. Financial Sources.